Two Sigma Securities’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-720
Closed -$34.2K 1418
2024
Q4
$34.2K Sell
720
-436
-38% -$26.4K ﹤0.01% 1231
2024
Q3
$114K Buy
1,156
+528
+84% +$68.2K ﹤0.01% 2255
2024
Q2
$103K Buy
+628
New +$89.5K ﹤0.01% 2476
2024
Q1
Sell
-516
Closed -$162K 2903
2023
Q4
$162K Sell
516
-444
-46% -$161K ﹤0.01% 2456
2023
Q3
$426K Buy
960
+500
+109% +$226K ﹤0.01% 1651
2023
Q2
$199K Buy
+460
New +$259K ﹤0.01% 2225

Other funds holding AGL

Two Sigma Securities's AGL Position: Q1 2026 in Review

Two Sigma Securities sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 3,360 shares — an estimated $57.8K sold.

Two Sigma Securities first reported a position in AGL in Q2 2024 and held it in 5 quarters. The position peaked at $97.1K in Q2 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Two Sigma Securities reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,360 Agilon Health shares in Q1 2026, an estimated $57.8K.
  • Two Sigma Securities first reported a position in Agilon Health in Q2 2024 and held it in 5 quarters.
  • Two Sigma Securities's Agilon Health position peaked at $97.1K in Q2 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.